<DOC>
	<DOCNO>NCT00067236</DOCNO>
	<brief_summary>The main purpose study test whether possible new drug ( call PG-116800 ) prevent damage heart muscle patient heart attack . The study also supply information regard possible us compound cardiovascular disease .</brief_summary>
	<brief_title>Study Oral PG-116800 Following Heart Attack</brief_title>
	<detailed_description>Heart attack cause damage heart muscle weaken heart lead change shape pump ability heart . These change lead heart failure . An enzyme call metalloproteinase ( MMP ) play role damage . The main purpose study test whether possible new drug ( call PG-116800 ) interfere MMP enzyme prevent damage heart muscle patient heart attack . The study also supply information regard possible us compound cardiovascular disease . This Phase II `` proof-of-concept '' study ; , first attempt treat sick people drug see work . The study interventional since use drug interfere heart tissue damage follow heart attack .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomegaly</mesh_term>
	<criteria>Inclusion : Be least 18 year age old 80 year age screening ; Be diagnose heart attack base electrocardiogram ( ECG ) cardiac enzymes criterion ; The qualify heart attack first heart attack ; The qualify heart attack result leave ventricular ejection fraction ( measure work efficiency heart ) 15 % 40 % . Exclusion : Documented previous history heart attack ; Any past history heart failure ; Hemodynamic instability ( instability circulatory system ) ; History congenital heart disease cardiomyopathy ( weakened heart muscle ) associate connective tissue disorder ; Recent history current moderatetosevere kidney liver impairment ; Significant blood dyscrasia ( disorder blood cell ) ; Females currently : pregnant ; breastfeeding ; childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>